has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.Online First from The Oncologist
- Is “Geriatric” Assessment Just for Older Patients?
- Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population‐Based Study
- Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population
- Potential Life‐Years Lost: The Impact of the Cancer Drug Regulatory and Funding Process in Canada
- Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers
Clinical Trials Results from The Oncologist
- A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors [CLINICAL TRIAL RESULTS]
- Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer [CLINICAL TRIAL RESULTS]
- Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up [CLINICAL TRIAL RESULTS]
- A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors [CLINICAL TRIAL RESULTS]
- Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy [CLINICAL TRIAL RESULTS]